Advances in our understanding of the signal transduction pathways involved
in cellular growth control have provided several new strategies for cancer
therapy. Recent advances now make it possible to develop selective inhibito
rs targeting genomic instability, the growth, survival, and invasion of the
tumor, and its nourishment through the growth of new blood vessels.